14 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
7 Jan 19
Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
9:03am
and our innovative platform will enable us to rapidly advance important new treatments for influenza, which is a significant worldwide unmet need
8-K
EX-99.1
3cdjlhphx9 5uojk8
1 May 18
Cocrystal Pharma, Inc., Prices $8,000,000 Common Stock Offering
8:35am
CORRESP
ia4o7soyzret
19 Dec 11
Correspondence with SEC
12:00am
S-1
xrm28
21 Sep 11
IPO registration
12:00am
8-K
q0i fkj004y0chgov
19 May 11
Completion of Acquisition or Disposition of Assets
12:00am
- Prev
- 1
- Next